Industry Experience | 26 years
Prior Experience | Amgen, Insmed
Mr. Farrar has over 26 years of biotech industry experience, including 18 years with Amgen. He has extensive experience in process development, clinical manufacturing, commercial manufacturing, and his responsibilities have included cell-line development, cell banking, fermentation/cell culture, purification, fill/finish, and lyophilization operations.
Mr. Farrar has been involved in filing 13 Investigational New Drug (IND) Applications and two Biological License Applications (BLAs), and has worked with more than two dozen products produced by recombinant DNA technology in microbial, yeast and mammalian cells. He has managed over $400 million in capital projects and built a process development pilot plant and a multiproduct clinical manufacturing plant from the ground up, as well as expanded, renovated, and retooled commercial manufacturing facilities capable of outputs from hundreds of kilogram to multi-metric tons.
Prior to Coherus Biosciences, Mr. Farrar held the position of Senior Vice President of Pharmaceutical Operations at Insmed Therapeutic Proteins, where he was responsible for process research and development laboratories, manufacturing operations, contract manufacturing operations, logistics, engineering, and maintenance. While at Insmed he successfully developed a line of follow-on biologics, enabling in the sale of the business unit to Merck for $130 million in 2009.
Prior to Insmed, Mr. Farrar worked at Amgen Inc., starting in 1987 in Process Development as an engineer developing, optimizing and scaling-up processes for clinical and commercial production. In 1992, Mr. Farrar took on the role of clinical manufacturing plant manager, producing more than 20 products for use in Amgen clinical trials, seven of which later became commercial products. Mr. Farrar was responsible for the design, construction, and start-up of a new state-of-the-art clinical manufacturing facility to replace an older, smaller one.
In 1998, Mr. Farrar took on the role of plant manager of a large-scale Amgen production facility in Colorado. He successfully transitioned the plant from clinical to an FDA and EMEA licensed commercial production facility while accelerating timelines. Under his guidance, subsequent plant expansion and process improvements significantly increased plant output and capabilities. He has hosted numerous U.S. FDA, European, and Health Canada prior approval and periodic inspections in his production facilities.
Mr. Farrar received his B.S. degree in Chemical Engineering from the University of Missouri Rolla in 1986.